IBX Secures Additional Capital — Shareholders Exercise Options

IBX Secures Additional Capital — Shareholders Exercise Options

Imagion Biosystems announces that it has received a total of $369,689.99 for the exercise of options.

Please click to review the full announcement at ASX.

Related Articles

Imagion AGM Business Update

MELBOURNE – Imagion Biosystems (Company, ASX: IBX), a company dedicated to improving healthcare outcomes through the early detection of cancer, is pleased to provide shareholders

Read More

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.